Pancreas

• (107-18) A Phase 1b/2 Study of BMS-813160 in Combination with Chemotherapy or Nivolumab in Patients with Advanced Solid Tumors (Phase 1b/2 clinical trial, appropriate for patients with colorectal or pancreatic cancer.)
• (144-17) A Phase Ib Study of Guadecitabine (SGI-110) and Durvalumab (MEDI 4736) in Patients with Advanced Hepatocellular Carcinoma, Pancreatic Adenocarcinoma, and Cholangiocarcinoma/Gallbladder Cancer (0S-16-18: PIb (SGI-110) and (MEDI 4736)) (Phase 1b clinical trial, appropriate for patients with hepatocellular, pancreatic, and cholangiocarcinoma / gallbladder cancers.)